218 related articles for article (PubMed ID: 23039894)
1. B cell activating factor (BAFF) in the natural history of chronic hepatitis C virus liver disease and mixed cryoglobulinaemia.
Lake-Bakaar G; Jacobson I; Talal A
Clin Exp Immunol; 2012 Nov; 170(2):231-7. PubMed ID: 23039894
[TBL] [Abstract][Full Text] [Related]
2. Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia.
Calleja JL; Albillos A; Moreno-Otero R; Rossi I; Cacho G; Domper F; Yebra M; Escartín P
Aliment Pharmacol Ther; 1999 Sep; 13(9):1179-86. PubMed ID: 10468699
[TBL] [Abstract][Full Text] [Related]
3. Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.
Dammacco F; Tucci FA; Lauletta G; Gatti P; De Re V; Conteduca V; Sansonno S; Russi S; Mariggiò MA; Chironna M; Sansonno D
Blood; 2010 Jul; 116(3):343-53. PubMed ID: 20308602
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF).
Sène D; Limal N; Ghillani-Dalbin P; Saadoun D; Piette JC; Cacoub P
Rheumatology (Oxford); 2007 Jan; 46(1):65-9. PubMed ID: 16782735
[TBL] [Abstract][Full Text] [Related]
5. Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors.
Gragnani L; Piluso A; Giannini C; Caini P; Fognani E; Monti M; Petrarca A; Ranieri J; Razzolini G; Froio V; Laffi G; Zignego AL
Arthritis Rheum; 2011 May; 63(5):1446-51. PubMed ID: 21538321
[TBL] [Abstract][Full Text] [Related]
6. Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.
Saadoun D; Resche Rigon M; Sene D; Terrier B; Karras A; Perard L; Schoindre Y; Coppéré B; Blanc F; Musset L; Piette JC; Rosenzwajg M; Cacoub P
Blood; 2010 Jul; 116(3):326-34; quiz 504-5. PubMed ID: 20439619
[TBL] [Abstract][Full Text] [Related]
7. Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis.
Saadoun D; Resche-Rigon M; Sene D; Perard L; Karras A; Cacoub P
Ann Rheum Dis; 2008 Oct; 67(10):1431-6. PubMed ID: 18178690
[TBL] [Abstract][Full Text] [Related]
8. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
[TBL] [Abstract][Full Text] [Related]
9. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor.
Liao TL; Chen YM; Hsieh SL; Tang KT; Chen DY; Yang YY; Liu HJ; Yang SS
mBio; 2021 Dec; 12(6):e0276421. PubMed ID: 34724826
[TBL] [Abstract][Full Text] [Related]
11. Serum cytokine profile in hepatitis C virus carriers presenting cryoglobulinaemia and non-organ-specific autoantibodies.
Atta AM; Oliveira IS; Sousa GM; Paraná R; Atta ML
Microb Pathog; 2010 Feb; 48(2):53-6. PubMed ID: 20005287
[TBL] [Abstract][Full Text] [Related]
12. B-cell depletion in the treatment of mixed cryoglobulinemia.
Sansonno D; Tucci FA; Montrone M; Troiani L; Sansonno L; Gatti P; Lauletta G
Dig Liver Dis; 2007 Sep; 39 Suppl 1():S116-21. PubMed ID: 17936212
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease.
Lake-Bakaar G; Dustin L; McKeating J; Newton K; Freeman V; Frost SD
Blood; 2007 Jan; 109(2):845-6. PubMed ID: 17210867
[No Abstract] [Full Text] [Related]
14. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity.
Toubi E; Gordon S; Kessel A; Rosner I; Rozenbaum M; Shoenfeld Y; Zuckerman E
J Autoimmun; 2006 Sep; 27(2):134-9. PubMed ID: 17029886
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia.
Fornasieri A; Bernasconi P; Ribero ML; Sinico RA; Fasola M; Zhou J; Portera G; Tagger A; Gibelli A; D'amico G
Clin Exp Immunol; 2000 Dec; 122(3):400-3. PubMed ID: 11122246
[TBL] [Abstract][Full Text] [Related]
16. B cell homeostasis in chronic hepatitis C virus-related mixed cryoglobulinemia is maintained through naïve B cell apoptosis.
Holz LE; Yoon JC; Raghuraman S; Moir S; Sneller MC; Rehermann B
Hepatology; 2012 Nov; 56(5):1602-10. PubMed ID: 22556016
[TBL] [Abstract][Full Text] [Related]
17. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
[TBL] [Abstract][Full Text] [Related]
18. Association of BAFF -871C/T Promoter Polymorphism with Hepatitis C-Related Mixed Cryoglobulinemia in a Cohort of Egyptian Patients.
Ayad MW; Elbanna AA; Elneily DA; Sakr AS
Mol Diagn Ther; 2015 Apr; 19(2):99-106. PubMed ID: 25800158
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1β, C-x-C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis.
Antonelli A; Ferri C; Ferrari SM; De Marco S; Di Domenicantonio A; Centanni M; Pupilli C; Villa E; Menichetti F; Fallahi P
J Interferon Cytokine Res; 2010 Nov; 30(11):835-42. PubMed ID: 20929277
[TBL] [Abstract][Full Text] [Related]
20. B-cell-activating factor affects the occurrence of thyroid autoimmunity in chronic hepatitis C patients treated with interferon alpha.
Kajiyama Y; Kikuchi K; Takai A; Hosoya N; Hoshino H; Hino K; Miyakawa H
Clin Dev Immunol; 2012; 2012():247973. PubMed ID: 22481965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]